We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Lightweight CPAP Device Promotes Patient Mobility

By HospiMedica International staff writers
Posted on 25 Dec 2013
Print article
Image: The Z1 CPAP device and PowerShell battery module (Photo courtesy of Human Design Medical).
Image: The Z1 CPAP device and PowerShell battery module (Photo courtesy of Human Design Medical).
An innovative continuous positive airway pressure (CPAP) is changing the rules of design, portability, and user experience.

The Z1 CPAP device fits in the palm of the hand and weighs an exceptionally light 285 grams. In addition to all the full features CPAP users need, the Z1 also includes embedded Bluetooth technology and data viewing software that offer users feedback on their therapy. The proprietary Z-Breathe algorithm learns the users breathing patterns to relieve CPAP machine pressure upon exhalation. A backlit liquid crystal diode (LCD) display and tactical buttons provides users with feedback and easy-to-use controls so users can monitor session status.

An optional PowerShell houses an integrated 14.4 V lithium ion overnight battery module within a neoprene case, which enables users to use plug-in power or the cordless battery module, which delivers at least eight hours of CPAP without external power. If there is a power outage, the Z1 automatically transfers over to battery power so patients can continue their sleep without interruption. It also provides an ideal solution for camping, boating, or any other lifestyle activities where external power sources are limited or not available. The Z1 CPAP device is a product of Human Design Medical (HDM; Boston, MA, USA), and is compatible with all CPAP masks on the market.

“We think that if we can engage device users in a more meaningful way, and create products that they actually like to use, we can be an integral part of their lifestyle and improve their quality of life,” said Steve Moore, senior VP of Sales and Marketing at HDM. “Our goal was to make CPAP treatment more user-friendly for people with active lifestyles and I think we really nailed it. I am a CPAP user myself and have taken the Z1 on business trips across the US and overseas and I can attest to the value of having CPAP that is ready to go wherever I need it to, while taking up as little space as possible.”

CPAP is the use of continuous, constant flow of air to maintain a continuous level of positive airway pressure. The ventilator does not cycle during CPAP, no additional pressure above the level of CPAP is provided, and patients must initiate all of their breaths. CPAP typically is used for people who have breathing problems, such as sleep apnea. CPAP is the most effective treatment for obstructive sleep apnea (OSA), in which the mild pressure from CPAP prevents the airway from collapsing or becoming blocked.

Related Links:

Human Design Medical


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Sling
GoComfort
New
Anesthetic Gas Measurement Module
Scio Four

Print article

Channels

Surgical Techniques

view channel
Image: Younger patients with asymptomatic AS who undergo TAVR experience lower rates of serious cardiovascular events (Photo courtesy of Shutterstock)

Early TAVR Intervention Reduces Cardiovascular Events in Asymptomatic Aortic Stenosis Patients

Each year, approximately 300,000 Americans are diagnosed with aortic stenosis (AS), a serious condition that results from the narrowing or blockage of the aortic valve in the heart. Two common treatments... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more